Definitive Contract 75N91020C00023
Award Date
9/16/20
Potential Completion Date
7/15/21
Potential Value
$387K
Federal Agency
National Cancer Institute
Awardee
Biodata Consortium, LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30306, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS - NIH) awarded a $1,998,445 Definitive Contract to Impact Business Information Solutions, Inc. of Princeton, New Jersey. The contract is for the provision of AUTOMATED DEIDENTIFICATION OF PATHOLOGY AND RADIOLOGY DATA services over a two-year period from August 15, 2023 through August 14, 2025. The pricing structure is Firm Fixed Price. The contract was set aside for Total Small Business. No...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Infotech Soft, Inc., a woman-owned small business. The contract, valued at $223,808.00, is for the development of a "Platform for High-Throughput Analysis of Integrated Cancer Imaging and Multi-Omics Data" under SBIR Topic #364. The contract is a Definitive Contract with a Firm Fixed Price...
This federal contract award, valued at $395,613.00, was issued by the National Cancer Institute (NCI) to Impact Business Information Solutions, Inc., doing business as Solutions Inc. The contract is a Small Business Innovation Research (SBIR) Phase I award, designated as a total small business set-aside. The contract aims to develop a "Unified Data Commons Solution for Public Domain, In-House and Third-Party Multimodal Clinical Data", which supports advanced data management and...
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
Impact Business Information Solutions, Inc. was awarded a $441,720 firm fixed price contract by the National Institutes of Health National Cancer Institute to conduct research under Phase I of the Small Business Innovation Research program. The contract is for one year beginning September 16, 2021 through September 15, 2022 to perform work on Topic 427, which involves developing automated methods for deidentifying pathology and radiology data. This award was made under Solicitation PHS-2021-1 by...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Babel Analytics LLC, a self-certified small disadvantaged business, woman-owned small business, and Asian-Pacific American-owned limited liability company. The contract, valued at $447,633.00, is for the development of Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. This SBIR Phase I...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Reveal Biosciences Inc., a self-certified small disadvantaged business, for SBIR Phase I efforts on the topic of "Artificial Intelligence-Aided Imaging for Cancer Prevention, Diagnosis, and Monitoring." The potential value of the contract is $392,343.00. Reveal Biosciences is a computational pathology company that...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute, which is part of the Department of Health and Human Services' National Institutes of Health. The contract, valued at $397,457, is with Kitware Inc., a for-profit software company, to develop image de-identification capabilities or accelerate cancer research using advanced imaging techniques. The contract is set aside for small businesses. Kitware is known for providing open source...
The National Cancer Institute, a component of the Department of Health and Human Services, awarded a $489,805 firm fixed price purchase order to Biofortis, LLC. The contract provides for Biofortis Labmatrix clinical and translational research management software subscriptions, maintenance, and development support services over a base period of performance from August 2021 through August 2022. The original solicitation sought these capabilities on a sole source basis from Biofortis to provide...